Durgical
EN
Open the app

The bleeding patient on an anticoagulant: assess, stop, reverse

  • Approach to a complaint

Blood thinners save many lives but make every bleed worse. In a serious bleed, knowing which drug and when it was last taken decides how to undo it.

Updated

What it is

Patients taking anticoagulants (vitamin K antagonists such as warfarin, direct thrombin inhibitors such as dabigatran, factor Xa inhibitors such as rivaroxaban and apixaban, and heparins) bleed more often and more severely. The approach classifies the bleed as major or minor: major bleeding is bleeding with haemodynamic compromise, bleeding in a critical site (intracranial, spinal, pericardial, intraocular, airway, a muscle compartment or the retroperitoneum) or bleeding that needs transfusion. It then identifies the drug, the time of the last dose and kidney function (which clears dabigatran and, in part, the factor Xa inhibitors), and chooses reversal. Major bleeding on a vitamin K antagonist is reversed with intravenous vitamin K plus prothrombin complex concentrate (plasma if concentrate is unavailable); dabigatran with its specific antibody fragment (idarucizumab) where available; factor Xa inhibitors with andexanet alfa where available or prothrombin complex concentrate; unfractionated heparin with protamine, which only partly reverses low-molecular-weight heparin. Minor bleeding is managed with local measures and by holding or adjusting the drug. The risk of clotting once the drug is stopped is weighed with the specialist.

Red flags

  • Hypotension, tachycardia or falling haemoglobin.
  • Headache, vomiting, reduced consciousness or new deficit after even minor head trauma.
  • Back pain with leg weakness (spinal haematoma), flank or groin pain (retroperitoneal bleed).
  • Tense, painful limb after a fall (compartment bleeding).
  • Haematemesis, melaena, massive haematuria or haemoptysis.
  • Unexplained bleeding with very prolonged clotting times and no anticoagulant prescribed: rodenticide (superwarfarin) poisoning.

Step-by-step approach

  1. ABCDE, local pressure, two large cannulas, group and crossmatch — control the bleeding you can see and prepare for the one you cannot.
  2. Classify: major (unstable, critical site, needs transfusion) or minor — the class decides whether to reverse.
  3. Identify the drug, last dose time, kidney function, antiplatelets and the reason for anticoagulation — they set the reversal and the clot risk.
  4. Send blood count, PT/INR, aPTT, fibrinogen, creatinine; drug-specific tests if available — routine tests may look normal on a factor Xa inhibitor.
  5. Major bleed on warfarin: intravenous vitamin K plus prothrombin complex concentrate — vitamin K alone takes many hours.
  6. Major bleed on dabigatran: idarucizumab; on a factor Xa inhibitor: andexanet alfa or prothrombin complex concentrate — match agent to drug.
  7. Heparin infusion: stop it and give protamine — it fully reverses unfractionated heparin, partly low-molecular-weight heparin.
  8. Treat the source: endoscopy, surgery, embolisation, neurosurgery — reversal buys time; it does not close the vessel.
  9. Minor bleed: local measures, hold or adjust the drug, plan its restart — stopping the drug has its own risk of stroke or clot.

Anticoagulants and how to undo them in major bleeding

Drug groupWhere it actsTest that reflects itSpecific reversal
Vitamin K antagonists (warfarin)Stop the liver making factors II, VII, IX, XPT/INRIV vitamin K plus prothrombin complex concentrate
Direct thrombin inhibitor (dabigatran)Blocks thrombinaPTT, thrombin time (sensitive), specific assaysIdarucizumab; dialysis removes it
Factor Xa inhibitors (rivaroxaban, apixaban)Block factor XaDrug-calibrated anti-Xa level; PT may be normalAndexanet alfa where available, or prothrombin complex concentrate
Unfractionated heparinBoosts antithrombin against thrombin and XaaPTT or anti-XaProtamine (complete reversal)
Low-molecular-weight heparinBoosts antithrombin mainly against XaAnti-XaProtamine (partial reversal)

Keys to the differential

  • An older patient on an anticoagulant who falls and hits the head may look well at first; delayed intracranial bleeding is a known risk.
  • A raised INR without bleeding usually needs only withholding warfarin and sometimes oral vitamin K, not concentrates.
  • Superwarfarin rodenticides are available in Colombia; accidental or deliberate ingestion causes prolonged coagulopathy needing vitamin K for weeks.
  • Antiplatelet drugs worsen bleeding too; routine platelet transfusion is not helpful in most bleeds on antiplatelets and may harm in intracerebral haemorrhage.
  • A mechanical heart valve raises the stakes of reversal: discuss with cardiology, but a life-threatening bleed still comes first.

Next step

  • Blood count, PT/INR, aPTT, fibrinogen, creatinine, group and crossmatch; specific drug levels where available.
  • CT of the head for any head injury or neurological symptom on an anticoagulant.
  • Major bleed: reversal according to the drug, source control and ICU or monitored bed.
  • Discuss restarting the anticoagulant with the treating team once the bleed is controlled.
  • Minor bleed: discharge with local measures, written advice and a clear plan for the next dose.

Common traps

  • Normal PT and aPTT mean no anticoagulant effect: factor Xa inhibitors can leave routine tests normal; ask about the last dose.
  • Fresh frozen plasma is the best warfarin reversal: prothrombin complex concentrate acts faster and needs less volume; vitamin K is always added.
  • Vitamin K alone reverses warfarin quickly: it takes many hours, so a major bleed also needs factor concentrate.
  • Every bleed on an anticoagulant needs reversal: minor bleeds are managed locally, because reversal exposes the patient to the clot.
  • Protamine reverses all heparins fully: it only partly neutralises low-molecular-weight heparin.

Test yourself

Think of the answer, then tap the question to see it.

A woman on warfarin has a large intracerebral haemorrhage and an INR of 4. What reversal does she need, and why both parts?

IV vitamin K plus prothrombin complex concentrate. The concentrate replaces factors within minutes; vitamin K restores their production over hours so the effect lasts.

A man on apixaban has melaena and normal PT and aPTT. Can you conclude the drug is not active?

No. Routine tests are insensitive to factor Xa inhibitors. The time of his last tablet and kidney function, or a calibrated anti-Xa level, show the effect.

Which anticoagulant can be removed by dialysis, and why does kidney function matter for it?

Dabigatran. It is mostly cleared by the kidneys and little bound to protein, so poor kidney function prolongs its effect and dialysis can remove it.

A patient on rivaroxaban has a small nosebleed controlled with pressure. Does he need a reversal agent?

No. Minor bleeding is managed with local measures and review of the drug; reversal would expose him to the clot the drug prevents without benefit.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of emergency medicine

Educational content; it does not replace supervised training, your institution's protocols or a medical assessment. It contains no doses. In a real emergency, call the emergency number (123 in Colombia) or go to the nearest emergency department; for poisoning, contact the toxicology line (CIATOX in Colombia).

Sources: Perioperative Anticoagulation Management (StatPearls (NCBI Bookshelf), 2023); Interpretation of Blood Clotting Studies and Values (PT, PTT, aPTT, INR, Anti-Factor Xa, D-Dimer) (StatPearls (NCBI Bookshelf), 2024); Warfarin: MedlinePlus Drug Information (MedlinePlus, US National Library of Medicine, 2026); Anticoagulant rodenticides poisoning (MedlinePlus, US National Library of Medicine, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.